<!doctype html><html lang=en-us><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=generator content="Source Themes Academic 4.5.0"><meta name=author content="Somnath Rakshit"><meta name=description content="The microRNA (miRNA) biomolecules have a significant role in the development of breast cancer, and their expression profile is different in each subtype of breast cancer. Thus, our goal is to use the Next Generation Sequencing provided high-throughput miRNA expression and clinical data in an integrated fashion to perform survival analysis in order to identify breast cancer subtype specific miRNAs, and analyze associated genes and transcription factors. We select top 100 miRNAs for each of the four subtypes, based on the value of hazard ratio and p-value, thereafter, identify 44 miRNAs that are related to all four subtypes, which we call as 4-star miRNAs. Moreover, 12, 14, 9 and 15 subtype specific, viz. 1-star miRNAs, are also identified. The resulting miRNAs are validated by using machine learning methods to differentiate tumor cases from controls (for 4-star miRNAs), and subtypes (for 1-star miRNAs). The 4-star miRNAs provide 95% average accuracy, while in case of 1-star miRNAs 81% accuracy is achieved for HER2-Enriched. Differences in expression of miRNAs between cancer stages is also analyzed, and a subset of 8 miRNAs is found, for which expression is increased in stage II relative to stage I, including hsa-miR-10b-5p, which contributes to breast cancer metastasis. Subsequently we prepare regulatory networks in order to identify the interactions among miRNAs, their targeted genes and transcription factors (TFs), that are targeting those miRNAs. In this way, key regulatory circuits are identified, where genes such as TP53, ESR1, BRCA1, MYC and others, that are known to be important genetic factors for the cause of breast cancer, produce transcription factors that target the same genes as well as interact with the selected miRNAs. To provide further biological validation the Protein-Protein Interaction (PPI) networks are prepared and KEGG pathway and GO enrichment analysis are performed. Among the enriched pathways many are breast cancer-related, such as PI3K-Akt or p53 signaling pathways, and contain proteins such as TP53, also present in the regulatory networks. Moreover, we find that the genes are enriched in GO terms associated with breast cancer. Our results provide detailed analysis of selected miRNAs and their regulatory networks."><link rel=alternate hreflang=en-us href=https://somnathrakshit.github.io/publication/mirna-breast-cancer-subtypes/><meta name=theme-color content=#2962ff><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin=anonymous><link rel=stylesheet href=https://use.fontawesome.com/releases/v5.6.0/css/all.css integrity=sha384-aOkxzJ5uQz7WBObEZcHvV5JvRW3TUc2rNPA7pe3AwnsUohiw1Vj2Rgx2KSOkF5+h crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/styles/github.min.css crossorigin=anonymous title=hl-light><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/styles/dracula.min.css crossorigin=anonymous title=hl-dark disabled><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Montserrat:400,700%7CRoboto:400,400italic,700%7CRoboto+Mono&display=swap"><link rel=stylesheet href=/css/academic.min.04a87a1cb9027e3c50f566322527c56f.css><script>window.ga=window.ga||function(){(ga.q=ga.q||[]).push(arguments)};ga.l=+new Date;ga('create','UA-107696056-2','auto');ga('require','eventTracker');ga('require','outboundLinkTracker');ga('require','urlChangeTracker');ga('send','pageview');</script><script async src=https://www.google-analytics.com/analytics.js></script><script async src=https://cdnjs.cloudflare.com/ajax/libs/autotrack/2.4.1/autotrack.js integrity="sha512-HUmooslVKj4m6OBu0OgzjXXr+QuFYy/k7eLI5jdeEy/F4RSgMn6XRWRGkFi5IFaFgy7uFTkegp3Z0XnJf3Jq+g==" crossorigin=anonymous></script><link rel=manifest href=/index.webmanifest><link rel=icon type=image/png href=/img/icon-32.png><link rel=apple-touch-icon type=image/png href=/img/icon-192.png><link rel=canonical href=https://somnathrakshit.github.io/publication/mirna-breast-cancer-subtypes/><meta property=twitter:card content=summary><meta property=twitter:site content=@_SomnathRakshit><meta property=twitter:creator content=@_SomnathRakshit><meta property=og:site_name content="Somnath Rakshit"><meta property=og:url content=https://somnathrakshit.github.io/publication/mirna-breast-cancer-subtypes/><meta property=og:title content="Identification of Breast Cancer subtype specific MicroRNAs using Survival Analysis to find their role in transcriptomic regulation  | Somnath Rakshit"><meta property=og:description content="The microRNA (miRNA) biomolecules have a significant role in the development of breast cancer, and their expression profile is different in each subtype of breast cancer. Thus, our goal is to use the Next Generation Sequencing provided high-throughput miRNA expression and clinical data in an integrated fashion to perform survival analysis in order to identify breast cancer subtype specific miRNAs, and analyze associated genes and transcription factors. We select top 100 miRNAs for each of the four subtypes, based on the value of hazard ratio and p-value, thereafter, identify 44 miRNAs that are related to all four subtypes, which we call as 4-star miRNAs. Moreover, 12, 14, 9 and 15 subtype specific, viz. 1-star miRNAs, are also identified. The resulting miRNAs are validated by using machine learning methods to differentiate tumor cases from controls (for 4-star miRNAs), and subtypes (for 1-star miRNAs). The 4-star miRNAs provide 95% average accuracy, while in case of 1-star miRNAs 81% accuracy is achieved for HER2-Enriched. Differences in expression of miRNAs between cancer stages is also analyzed, and a subset of 8 miRNAs is found, for which expression is increased in stage II relative to stage I, including hsa-miR-10b-5p, which contributes to breast cancer metastasis. Subsequently we prepare regulatory networks in order to identify the interactions among miRNAs, their targeted genes and transcription factors (TFs), that are targeting those miRNAs. In this way, key regulatory circuits are identified, where genes such as TP53, ESR1, BRCA1, MYC and others, that are known to be important genetic factors for the cause of breast cancer, produce transcription factors that target the same genes as well as interact with the selected miRNAs. To provide further biological validation the Protein-Protein Interaction (PPI) networks are prepared and KEGG pathway and GO enrichment analysis are performed. Among the enriched pathways many are breast cancer-related, such as PI3K-Akt or p53 signaling pathways, and contain proteins such as TP53, also present in the regulatory networks. Moreover, we find that the genes are enriched in GO terms associated with breast cancer. Our results provide detailed analysis of selected miRNAs and their regulatory networks."><meta property=og:image content=https://somnathrakshit.github.io/img/icon-192.png><meta property=twitter:image content=https://somnathrakshit.github.io/img/icon-192.png><meta property=og:locale content=en-us><meta property=article:published_time content=2019-09-30T23:54:41-05:00><meta property=article:modified_time content=2019-09-30T23:54:41-05:00><script type=application/ld+json>{"@context":"https://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://somnathrakshit.github.io/publication/mirna-breast-cancer-subtypes/"},"headline":"Identification of Breast Cancer subtype specific MicroRNAs using Survival Analysis to find their role in transcriptomic regulation ","datePublished":"2019-09-30T23:54:41-05:00","dateModified":"2019-09-30T23:54:41-05:00","publisher":{"@type":"Organization","name":"Somnath Rakshit","logo":{"@type":"ImageObject","url":"https://somnathrakshit.github.io/img/icon-512.png"}},"description":"The microRNA (miRNA) biomolecules have a significant role in the development of breast cancer, and their expression profile is different in each subtype of breast cancer. Thus, our goal is to use the Next Generation Sequencing provided high-throughput miRNA expression and clinical data in an integrated fashion to perform survival analysis in order to identify breast cancer subtype specific miRNAs, and analyze associated genes and transcription factors. We select top 100 miRNAs for each of the four subtypes, based on the value of hazard ratio and p-value, thereafter, identify 44 miRNAs that are related to all four subtypes, which we call as 4-star miRNAs. Moreover, 12, 14, 9 and 15 subtype specific, viz. 1-star miRNAs, are also identified. The resulting miRNAs are validated by using machine learning methods to differentiate tumor cases from controls (for 4-star miRNAs), and subtypes (for 1-star miRNAs). The 4-star miRNAs provide 95% average accuracy, while in case of 1-star miRNAs 81% accuracy is achieved for HER2-Enriched. Differences in expression of miRNAs between cancer stages is also analyzed, and a subset of 8 miRNAs is found, for which expression is increased in stage II relative to stage I, including hsa-miR-10b-5p, which contributes to breast cancer metastasis. Subsequently we prepare regulatory networks in order to identify the interactions among miRNAs, their targeted genes and transcription factors (TFs), that are targeting those miRNAs. In this way, key regulatory circuits are identified, where genes such as TP53, ESR1, BRCA1, MYC and others, that are known to be important genetic factors for the cause of breast cancer, produce transcription factors that target the same genes as well as interact with the selected miRNAs. To provide further biological validation the Protein-Protein Interaction (PPI) networks are prepared and KEGG pathway and GO enrichment analysis are performed. Among the enriched pathways many are breast cancer-related, such as PI3K-Akt or p53 signaling pathways, and contain proteins such as TP53, also present in the regulatory networks. Moreover, we find that the genes are enriched in GO terms associated with breast cancer. Our results provide detailed analysis of selected miRNAs and their regulatory networks."}</script><title>Identification of Breast Cancer subtype specific MicroRNAs using Survival Analysis to find their role in transcriptomic regulation | Somnath Rakshit</title></head><body id=top data-spy=scroll data-offset=70 data-target=#TableOfContents><aside class=search-results id=search><div class=container><section class=search-header><div class="row no-gutters justify-content-between mb-3"><div class=col-6><h1>Search</h1></div><div class="col-6 col-search-close"><a class=js-search href=#><i class="fas fa-times-circle text-muted" aria-hidden=true></i></a></div></div><div id=search-box><input name=q id=search-query placeholder=Search... autocapitalize=off autocomplete=off autocorrect=off spellcheck=false type=search></div></section><section class=section-search-results><div id=search-hits></div></section></div></aside><nav class="navbar navbar-light fixed-top navbar-expand-lg py-0 compensate-for-scrollbar" id=navbar-main><div class=container><a class=navbar-brand href=/>Somnath Rakshit</a>
<button type=button class=navbar-toggler data-toggle=collapse data-target=#navbar aria-controls=navbar aria-expanded=false aria-label="Toggle navigation">
<span><i class="fas fa-bars"></i></span></button><div class="collapse navbar-collapse" id=navbar><ul class="navbar-nav mr-auto"><li class=nav-item><a class=nav-link href=/#about><span>Home</span></a></li><li class=nav-item><a class=nav-link href=/project><span>Projects</span></a></li><li class=nav-item><a class="nav-link  active" href=/publication><span>Publications</span></a></li><li class=nav-item><a class=nav-link href=/post><span>Blog</span></a></li><li class=nav-item><a class=nav-link href=/files/Somnath_Rakshit_Resume.pdf><span>Resume</span></a></li></ul><ul class="navbar-nav ml-auto"><li class=nav-item><a class="nav-link js-search" href=#><i class="fas fa-search" aria-hidden=true></i></a></li><li class=nav-item><a class="nav-link js-dark-toggle" href=#><i class="fas fa-moon" aria-hidden=true></i></a></li></ul></div></div></nav><div class=pub><div class="article-container pt-3"><h1>Identification of Breast Cancer subtype specific MicroRNAs using Survival Analysis to find their role in transcriptomic regulation</h1><div class=article-metadata><div><span>Micha≈Ç Denkiewicz</span>, <span><a href=/authors/indrajit-saha/>Indrajit Saha</a></span>, <span><a href=/authors/admin/>Somnath Rakshit</a></span>, <span><a href=/authors/jnanendra-prasad-sarkar/>Jnanendra Prasad Sarkar</a></span>, <span><a href=/authors/dariusz-plewczynski/>Dariusz Plewczynski</a></span></div><span class=article-date>September 2019</span><div class=share-box aria-hidden=true><ul class=share><li><a href="https://twitter.com/intent/tweet?url=https://somnathrakshit.github.io/publication/mirna-breast-cancer-subtypes/&amp;text=Identification%20of%20Breast%20Cancer%20subtype%20specific%20MicroRNAs%20using%20Survival%20Analysis%20to%20find%20their%20role%20in%20transcriptomic%20regulation%20" target=_blank rel=noopener class=share-btn-twitter><i class="fab fa-twitter"></i></a></li><li><a href="https://www.facebook.com/sharer.php?u=https://somnathrakshit.github.io/publication/mirna-breast-cancer-subtypes/&amp;t=Identification%20of%20Breast%20Cancer%20subtype%20specific%20MicroRNAs%20using%20Survival%20Analysis%20to%20find%20their%20role%20in%20transcriptomic%20regulation%20" target=_blank rel=noopener class=share-btn-facebook><i class="fab fa-facebook-f"></i></a></li><li><a href="mailto:?subject=Identification%20of%20Breast%20Cancer%20subtype%20specific%20MicroRNAs%20using%20Survival%20Analysis%20to%20find%20their%20role%20in%20transcriptomic%20regulation%20&amp;body=https://somnathrakshit.github.io/publication/mirna-breast-cancer-subtypes/" target=_blank rel=noopener class=share-btn-email><i class="fas fa-envelope"></i></a></li><li><a href="https://www.linkedin.com/shareArticle?url=https://somnathrakshit.github.io/publication/mirna-breast-cancer-subtypes/&amp;title=Identification%20of%20Breast%20Cancer%20subtype%20specific%20MicroRNAs%20using%20Survival%20Analysis%20to%20find%20their%20role%20in%20transcriptomic%20regulation%20" target=_blank rel=noopener class=share-btn-linkedin><i class="fab fa-linkedin-in"></i></a></li><li><a href="https://web.whatsapp.com/send?text=Identification%20of%20Breast%20Cancer%20subtype%20specific%20MicroRNAs%20using%20Survival%20Analysis%20to%20find%20their%20role%20in%20transcriptomic%20regulation%20%20https://somnathrakshit.github.io/publication/mirna-breast-cancer-subtypes/" target=_blank rel=noopener class=share-btn-whatsapp><i class="fab fa-whatsapp"></i></a></li><li><a href="https://service.weibo.com/share/share.php?url=https://somnathrakshit.github.io/publication/mirna-breast-cancer-subtypes/&amp;title=Identification%20of%20Breast%20Cancer%20subtype%20specific%20MicroRNAs%20using%20Survival%20Analysis%20to%20find%20their%20role%20in%20transcriptomic%20regulation%20" target=_blank rel=noopener class=share-btn-weibo><i class="fab fa-weibo"></i></a></li></ul></div></div><div class="btn-links mb-3"><a class="btn btn-outline-primary my-1 mr-1" href=http://www.nitttrkol.ac.in/indrajit/projects/mirna-survival-breastcancer-subtypes/downloads/codes/code.zip target=_blank rel=noopener>Code</a>
<a class="btn btn-outline-primary my-1 mr-1" href=http://www.nitttrkol.ac.in/indrajit/projects/mirna-survival-breastcancer-subtypes/#datasets target=_blank rel=noopener>Dataset</a>
<a class="btn btn-outline-primary my-1 mr-1" href=http://www.nitttrkol.ac.in/indrajit/projects/mirna-survival-breastcancer-subtypes/ target=_blank rel=noopener>Project</a>
<a class="btn btn-outline-primary my-1 mr-1" href=https://doi.org/10.3389/fgene.2019.01047 target=_blank rel=noopener>DOI</a></div></div><div class=article-container><h3>Abstract</h3><p class=pub-abstract>The microRNA (miRNA) biomolecules have a significant role in the development of breast cancer, and their expression profile is different in each subtype of breast cancer. Thus, our goal is to use the Next Generation Sequencing provided high-throughput miRNA expression and clinical data in an integrated fashion to perform survival analysis in order to identify breast cancer subtype specific miRNAs, and analyze associated genes and transcription factors. We select top 100 miRNAs for each of the four subtypes, based on the value of hazard ratio and p-value, thereafter, identify 44 miRNAs that are related to all four subtypes, which we call as 4-star miRNAs. Moreover, 12, 14, 9 and 15 subtype specific, viz. 1-star miRNAs, are also identified. The resulting miRNAs are validated by using machine learning methods to differentiate tumor cases from controls (for 4-star miRNAs), and subtypes (for 1-star miRNAs). The 4-star miRNAs provide 95% average accuracy, while in case of 1-star miRNAs 81% accuracy is achieved for HER2-Enriched. Differences in expression of miRNAs between cancer stages is also analyzed, and a subset of 8 miRNAs is found, for which expression is increased in stage II relative to stage I, including hsa-miR-10b-5p, which contributes to breast cancer metastasis. Subsequently we prepare regulatory networks in order to identify the interactions among miRNAs, their targeted genes and transcription factors (TFs), that are targeting those miRNAs. In this way, key regulatory circuits are identified, where genes such as TP53, ESR1, BRCA1, MYC and others, that are known to be important genetic factors for the cause of breast cancer, produce transcription factors that target the same genes as well as interact with the selected miRNAs. To provide further biological validation the Protein-Protein Interaction (PPI) networks are prepared and KEGG pathway and GO enrichment analysis are performed. Among the enriched pathways many are breast cancer-related, such as PI3K-Akt or p53 signaling pathways, and contain proteins such as TP53, also present in the regulatory networks. Moreover, we find that the genes are enriched in GO terms associated with breast cancer. Our results provide detailed analysis of selected miRNAs and their regulatory networks.</p><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Type</div><div class="col-12 col-md-9"><a href=/publication/#2>Journal article</a></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Publication</div><div class="col-12 col-md-9">Frontiers in Genetics: Systems Biology</div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=space-below></div><div class=article-style></div></div></div><script src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/highlight.min.js integrity="sha256-aYTdUrn6Ow1DDgh5JTc3aDGnnju48y/1c8s1dgkYPQ8=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/languages/python.min.js></script><script>hljs.initHighlightingOnLoad();</script><script>const search_index_filename="/index.json";const i18n={'placeholder':"Search...",'results':"results found",'no_results':"No results found"};const content_type={'post':"Posts",'project':"Projects",'publication':"Publications",'talk':"Talks"};</script><script id=search-hit-fuse-template type=text/x-template>
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script><script src=https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin=anonymous></script><script src=/js/academic.min.130521ecfc6f534c52c158217bbff718.js></script><div class=container><footer class=site-footer><p class=powered-by>&copy; Somnath Rakshit, 2020 &middot; .
<span class=float-right aria-hidden=true><a href=# id=back_to_top><span class=button_icon><i class="fas fa-chevron-up fa-2x"></i></span></a></span></p></footer></div><div id=modal class="modal fade" role=dialog><div class=modal-dialog><div class=modal-content><div class=modal-header><h5 class=modal-title>Cite</h5><button type=button class=close data-dismiss=modal aria-label=Close>
<span aria-hidden=true>&times;</span></button></div><div class=modal-body><pre><code class="tex hljs"></code></pre></div><div class=modal-footer><a class="btn btn-outline-primary my-1 js-copy-cite" href=# target=_blank><i class="fas fa-copy"></i>Copy</a>
<a class="btn btn-outline-primary my-1 js-download-cite" href=# target=_blank><i class="fas fa-download"></i>Download</a><div id=modal-error></div></div></div></div></div></body></html>